Australia markets close in 5 hours 29 minutes

Anavex Life Sciences Corp. (AVXL)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
3.3900-0.0200 (-0.59%)
At close: 04:00PM EDT
3.3700 -0.02 (-0.59%)
After hours: 06:05PM EDT
Show:
Income statement
Balance sheet
Annual

Cash flow

All numbers in thousands
Breakdown
ttm
30/09/2023
30/09/2022
30/09/2021
30/09/2020
Cash flows from operating activities
Net income
-43,155
-47,505
-47,978
-37,909
-26,280
Stock-based compensation
13,309
16,370
18,379
8,231
4,877
Change in working capital
-308
2,505
5,361
-706
116.518
Accounts payable
-996
497
-914
751
465.722
Other working capital
-29,309
-27,785
-24,238
-30,384
-21,287
Other non-cash items
-
845
-
-
-
Net cash provided by operating activities
-29,309
-27,785
-24,238
-30,384
-21,287
Cash flows from financing activities
Common stock issued
-
27,875
20,985
153,219
28,754
Other financing activities
-
-
-707
-5,551
-403.764
Net cash used provided by (used for) financing activities
29,452
29,651
21,288
153,243
28,350
Net change in cash
143
1,866
-2,950
122,859
7,063
Cash at beginning of period
143,622
149,158
152,108
29,249
22,186
Cash at end of period
143,765
151,024
149,158
152,108
29,249
Free cash flow
Operating cash flow
-29,309
-27,785
-24,238
-30,384
-21,287
Free cash flow
-29,309
-27,785
-24,238
-30,384
-21,287